The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Are Pretreatment 18F-FDG PET Tumor Textural Features in Non–Small Cell Lung Cancer Associated with Response and Survival After Chemoradiotherapy?
Open accessAbstract
UNLABELLED: There is evidence in some solid tumors that textural features of tumoral uptake in (18)F-FDG PET images are associated with response to chemoradiotherapy and survival. We have investigated whether a similar relationship exists in non-small cell lung cancer (NSCLC). METHODS: Fifty-three patients (mean age, 65.8 y; 31 men, 22 women) with NSCLC treated with chemoradiotherapy underwent pretreatment (18)F-FDG PET/CT scans. Response was assessed by CT Response Evaluation Criteria in Solid Tumors (RECIST) at 12 wk. Overall survival (OS), progression-free survival (PFS), and local PFS (LPFS) were recorded. Primary tumor texture was measured by the parameters coarseness, contrast, busyness, and complexity. The following parameters were also derived from the PET data: primary tumor standardized uptake values (SUVs) (mean SUV, maximum SUV, and peak SUV), metabolic tumor volume, and total lesion glycolysis. RESULTS: Compared with nonresponders, RECIST responders showed lower coarseness (mean, 0.012 vs. 0.027; P = 0.004) and higher contrast (mean, 0.11 vs. 0.044; P = 0.002) and busyness (mean, 0.76 vs. 0.37; P = 0.027). Neither complexity nor any of the SUV parameters predicted RECIST response. By Kaplan-Meier analysis, OS, PFS, and LPFS were lower in patients with high primary tumor coarseness (median, 21.1 mo vs. not reached, P = 0.003; 12.6 vs. 25.8 mo, P = 0.002; and 12.9 vs. 20.5 mo, P = 0.016, respectively). Tumor coarseness was an independent predictor of OS on multivariable analysis. Contrast and busyness did not show significant associations with OS (P = 0.075 and 0.059, respectively), but PFS and LPFS were longer in patients with high levels of each (for contrast: median of 20.5 vs. 12.6 mo, P = 0.015, and median not reached vs. 24 mo, P = 0.02; and for busyness: median of 20.5 vs. 12.6 mo, P = 0.01, and median not reached vs. 24 mo, P = 0.006). Neither complexity nor any of the SUV parameters showed significant associations with the survival parameters. CONCLUSION: In NSCLC, baseline (18)F-FDG PET scan uptake showing abnormal texture as measured by coarseness, contrast, and busyness is associated with nonresponse to chemoradiotherapy by RECIST and with poorer prognosis. Measurement of tumor metabolic heterogeneity with these parameters may provide indices that can be used to stratify patients in clinical trials for lung cancer chemoradiotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
Wahl, R. L., Jacene, H., Kasamon, Y., & Lodge, M. A. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.057307 · Cited by 3,777
Goldstraw, P., Crowley, J., Chansky, K., Giroux, D. J., Groome, P. A., Rami-Porta, R., Postmus, P. E., Rusch, V., & Sobin, L. (2007) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31812f3c1a · Cited by 3,655
Textural features corresponding to textural properties
Amadasun, M., & King, R. (1989) · IEEE Transactions on Systems, Man, and Cybernetics · doi:10.1109/21.44046 · Cited by 1,148
Tixier, F., Le Rest, C. C., Hatt, M., Albarghach, N., Pradier, O., Metges, J.-P., Corcos, L., & Visvikis, D. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.082404 · Cited by 696
Ganeshan, B., Panayiotou, E., Burnand, K., Dizdarevic, S., & Miles, K. (2012) · European Radiology · doi:10.1007/s00330-011-2319-8 · Cited by 505
Exploring feature-based approaches in PET images for predicting cancer treatment outcomes
El Naqa, I., Grigsby, P. W., Apte, A., Kidd, E., Donnelly, E., Khullar, D., Chaudhari, S., Yang, D., Schmitt, M., Laforest, R., et al. (2009) · Pattern Recognition · doi:10.1016/j.patcog.2008.08.011 · Cited by 480
Non–Small Cell Lung Cancer: Histopathologic Correlates for Texture Parameters at CT
Ganeshan, B., Goh, V., Mandeville, H. C., Ng, Q. S., Hoskin, P. J., & Miles, K. A. (2013) · Radiology · doi:10.1148/radiol.12112428 · Cited by 447
Self-citationGoh, V., Ganeshan, B., Nathan, P., Juttla, J. K., Vinayan, A., & Miles, K. A. (2011) · Radiology · doi:10.1148/radiol.11110264 · Cited by 367
Self-citationGaneshan, B., Abaleke, S., Young, R. C. D., Chatwin, C. R., & Miles, K. A. (2010) · Cancer Imaging · doi:10.1102/1470-7330.2010.0021 · Cited by 324
Tixier, F., Hatt, M., Le Rest, C. C., Le Pogam, A., Corcos, L., & Visvikis, D. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.099127 · Cited by 318
Ganeshan, B., Skogen, K., Pressney, I., Coutroubis, D., & Miles, K. (2012) · Clinical Radiology · doi:10.1016/j.crad.2011.08.012 · Cited by 310
Texture Analysis of Aggressive and Nonaggressive Lung Tumor CE CT Images
Al-Kadi, O. S., & Watson, D. (2008) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2008.919735 · Cited by 268
Spatial Heterogeneity in Sarcoma 18F-FDG Uptake as a Predictor of Patient Outcome
Eary, J. F., O'Sullivan, F., O'Sullivan, J., & Conrad, E. U. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.053397 · Cited by 213
Combined PET/CT image characteristics for radiotherapy tumor response in lung cancer
Vaidya, M., Creach, K. M., Frye, J., Dehdashti, F., Bradley, J. D., & El Naqa, I. (2012) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2011.10.014 · Cited by 201
Standardised FDG uptake: A prognostic factor for inoperable non-small cell lung cancer
Borst, G. R., Belderbos, J. S. A., Boellaard, R., Comans, E. F. I., Jaeger, K. D., Lammertsma, A. A., & Lebesque, J. V. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.03.026 · Cited by 184
Yu, H., Caldwell, C., Mah, K., & Mozeg, D. (2009) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2008.2004425 · Cited by 184
van Velden, F. H. P., Cheebsumon, P., Yaqub, M., Smit, E. F., Hoekstra, O. S., Lammertsma, A. A., & Boellaard, R. (2011) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-011-1845-6 · Cited by 182
Manus, M. M., Hicks, R., Matthews, J., Wirth, A., Rischin, D., & Ball, D. (2005) · Lung Cancer · doi:10.1016/j.lungcan.2004.11.024 · Cited by 164
Yu, H. J., Caldwell, C., Mah, K., Poon, I., Balogh, J. M., MacKenzie, R., Khaouam, N., & Tirona, R. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.04.043 · Cited by 140
Ohno, Y., Koyama, H., Yoshikawa, T., Matsumoto, K., Aoyama, N., Onishi, Y., & Sugimura, K. (2011) · American Journal of Roentgenology · doi:10.2214/ajr.11.6525 · Cited by 127
Chemotherapy Response Evaluation with 18F-FDG PET in Patients with Non-Small Cell Lung Cancer
de Geus‐Oei, L., van der Heijden, E. H. F. M., Visser, E. P., Hermsen, R., van Hoorn, B. A., Timmer-Bonte, J. N. H., Willemsen, A. T. M., Pruim, J., Corstens, F. H. M., Krabbe, P. F. M., et al. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.043414 · Cited by 121
Dooms, C., Verbeken, E., Stroobants, S., Nackaerts, K., Leyn, P. D., & Vansteenkiste, J. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.9550 · Cited by 118
Huang, W., Zhou, T., Ma, L., Sun, H., Gong, H., Wang, J., Yu, J., & Li, B. (2011) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-011-1838-5 · Cited by 114
Kido, S., Kuriyama, K., Higashiyama, M., Kasugai, T., & Kuroda, C. (2003) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-200301000-00011 · Cited by 77
Lee, D. H., Lee, D. H., Kim, S.-K., Lee, S., Lee, S. Y., Park, S. H., Kim, H. Y., Kang, K. W., Han, J., Kim, H. T., et al. (2009) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181a99fde · Cited by 76
Memon, A. A., Weber, B., Winterdahl, M., Jakobsen, S., Meldgaard, P., Madsen, H. H. T., Keiding, S., Nexø, E., & Sørensen, B. S. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.493 · Cited by 71
O'Brien, M. E. R., Myerson, J., Coward, J. I. G., Puglisi, M., Trani, L., Wotherspoon, A. C., Sharma, B., Cook, G., Ashley, S. E., Gunapala, R., et al. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.10.033 · Cited by 27
Self-citationPhantom Study on Radiotherapy Planning Using PET/CT
Uto, F., Shiba, E., ONOUE, S., Yoshimura, H., TAKADA, M., TSUJI, Y., Fukugami, S., Asakawa, I., Tamamoto, T., & Hasegawa, M. (2010) · Journal of Radiation Research · doi:10.1269/jrr.09063 · Cited by 25
Wiegman, E. M., Pruim, J., Ubbels, J. F., Groen, H. J. M., Langendijk, J. A., & Widder, J. (2011) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1706-8 · Cited by 19
Yoon, D. H., Baek, S., Choi, C., Lee, K. H., Suh, C., Ryu, J., Moon, D. H., Lee, J. S., & Kim, S.-W. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2791 · Cited by 17
Cited by
Applications and limitations of radiomics
Yip, S. S. F., & Aerts, H. J. W. L. (2016) · Physics in Medicine and Biology · doi:10.1088/0031-9155/61/13/r150 · Cited by 1,210
Machine Learning methods for Quantitative Radiomic Biomarkers
Parmar, C., Grossmann, P., Bussink, J., Lambin, P., & Aerts, H. J. W. L. (2015) · Scientific Reports · doi:10.1038/srep13087 · Cited by 1,019
Vallières, M., Freeman, C. R., Skamene, S. R., & El Naqa, I. (2015) · Physics in Medicine and Biology · doi:10.1088/0031-9155/60/14/5471 · Cited by 897
Intrinsic dependencies of CT radiomic features on voxel size and number of gray levels
Shafiq‐ul‐Hassan, M., Zhang, G. G., Latifi, K., Ullah, G., Hunt, D. C., Balagurunathan, Y., Abdalah, M. A., Schabath, M. B., Goldgof, D. G., Mackin, D., et al. (2017) · Medical Physics · doi:10.1002/mp.12123 · Cited by 585
Radiomics and radiogenomics in lung cancer: A review for the clinician
Thawani, R., McLane, M., Beig, N., Ghose, S., Prasanna, P., Velcheti, V., & Madabhushi, A. (2018) · Lung Cancer · doi:10.1016/j.lungcan.2017.10.015 · Cited by 450
Metadata
- Authors
- Cook, G. J. R., Yip, C., Siddique, M., Goh, V., Chicklore, S., Roy, A., Marsden, P., Ahmad, S., & Landau, D.
- Venue
- Journal of Nuclear Medicine
- Publisher
- Society of Nuclear Medicine
- Published
- 2012-11-30
- Volume
- 54
- Issue
- 1
- Pages
- 19-26
- ISSN
- 0161-5505 (ISSN-L)
- 2159-662X
- OpenAlex
- W2008108075
- Cited by
- 394
- References
- 30
- FWCI
- 16.69
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.